August 45, 2009 – Featherstone Informatics Group Inc. (FIG) this week said it was chosen as the exclusive vendor for the American College of Cardiology's practice-based quality improvement program, called the IC3 Program (Improving Continuous Cardiac Care).
August 5, 2009 – Stereotaxis Inc. said today clinicians performed more than 2,500 procedures with the magnetic irrigated catheter since its commercial release, and the major adverse cardiac event (MACE) rate for magnetic procedures remains at 0.1 percent.
August 5, 2009 – Nile Therapeutics Inc. said this week it dosed its first patient in a phase 2 clinical study of its lead product, CD-NP, for the treatment of acute heart failure.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 4, 2009 – Watson Pharmaceuticals Inc. said this week it received FDA approval on its abbreviated new drug applications (ANDAs) for metoprolol succinate extended-release tablets USP in the 25 mg and 50 mg strengths, which are the generic equivalent to AstraZeneca's Toprol XL tablets.
August 3, 2009 – Kowa Research Institute (KRI) and Kowa Pharmaceuticals America Inc. (KPA) said today the FDA has cleared LIVALO (pitavastatin), a potent HMG-CoA reductase inhibitor (statin) for the primary treatment of hypercholesterolemia and combined dyslipidemia. The company said the drug offers a new therapeutic option to a large, competitive market for cardiometabolic disorders.
August 3, 2009 – IDEAL LIFE Inc. said today its wireless remote monitoring devices were selected for a state-funded healthcare project to home monitor heart failure patients in six rural North Carolina communities.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 4, 2009 – The Yale University School of Medicine today announced the successful enrollment of more than 1,650 heart failure (HF) patients as part of the National Institutes of Health (NIH)-sponsored, Tele-HF study to evaluate the impact of device-free remote patient monitoring (RPM) on improving chronic care management and reducing hospitalizations of HF patients.
August 4, 2009 - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has submitted a proposal to Canada’s Expert Review Panel on Medical Isotope and Technetium-99m (Tc-99m) Generator Production, stating the best answer to the shortage of medical radioisotopes is the completion and bringing into service of the MAPLE project.
August 3, 2009 – Abbott is conducting a voluntary recall of its POWERSAIL Coronary Dilatation Catheters, which may be damaged and can cause a leak of contrast material during use, possibly leading to catheter functional failures, including air embolism and myocardial infarction.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 3, 2009 – Circulatory assist pump maker Thoratec Corp. and small implantable blood pump maker HeartWare International Inc. terminated their merger agreement in response to U.S. Federal Trade Commission’s complaint in the U.S. Federal District Court challenging the proposed acquisition.
July 31, 2009 – Theregen Inc. said its Anginera heart patch, a living three-dimensional engineered human tissue, was used as the foundation for the ”living band-aid for the heart,” as reported recently at the 2009 American Heart Association Cardiovascular Sciences Conference in Las Vegas, NV.
July 31, 2009 – Heart Force Medical Inc. this week received FDA clearance for its digital Ballistocardiograph (dBG), a noninvasive device to assess cardiac performance by measuring and monitoring the mechanical action of the heart.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 31, 2009 – A United Kingdom court has determined Occlutech GmbH’s products do not infringe on AGA Medical Holdings’ patents for atrial septal defects (ASD) and patent foramen ovale (PFO) occlusion devices.
July 31, 2009 – United Therapeutics Corp. said yesterday the FDA approved TYVASO (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertension (PAH) using the TYVASO Inhalation System (which includes the Optineb-ir device and accessories).
July 30, 2009 – The Federal Trade Commission today authorized a lawsuit to block Thoratec Corp’s proposed $282 million acquisition of rival HeartWare International Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (LVADs).